Aberrant methylation of tissue factor pathway inhibitor-2 is a biomarker for HSIL and squamous cell carcinoma of the cervix

被引:0
|
作者
Bin Yang [1 ]
Ji, Xin [1 ]
Scheidemantel, Thomas [1 ]
Abu Shahin, Fadi [1 ]
机构
[1] Cleveland Clin, Cleveland, OH USA
来源
CANCER CYTOPATHOLOGY | 2007年 / 111卷 / 05期
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PF7
引用
收藏
页码:349 / 350
页数:2
相关论文
共 50 条
  • [41] Adenovirus Mediated Expression of Tissue Factor Pathway Inhibitor-2 Inhibits Endothelial Cell Migration and Angiogenesis
    Ivanciu, L.
    Gerard, R.
    Tang, H.
    Lupu, C.
    Lupu, F.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 : 68 - 68
  • [42] Aberrant methylation of genes in oral squamous cell carcinoma
    Goot-Heah, Khor
    Froemming, Gabriele Ruth Anisah
    Zain, Rosnah Binti
    Abraham, Mannil Thomas
    Omar, Effat
    Su-Keng, Tan
    Kwai-Lin, Thong
    ORAL ONCOLOGY, 2013, 49 : S6 - S7
  • [43] Prognostic significance of tissue factor pathway inhibitor-2 in pancreatic carcinoma and its effect on tumor invasion and metastasis
    Zhigang Tang
    Guangyong Geng
    Qiang Huang
    Geliang Xu
    Hejie Hu
    Jiong Chen
    Jiansheng Li
    Medical Oncology, 2010, 27 : 867 - 875
  • [44] Aberrant DNA Methylation in Cutaneous Squamous Cell Carcinoma
    Li FengJuan
    Wu Yi
    Lv Qun
    Yang XueYuan
    Jiang MingJun
    Li LiMing
    国际皮肤性病学杂志(英文), 2019, 2 (04)
  • [45] Prognostic significance of tissue factor pathway inhibitor-2 in pancreatic carcinoma and its effect on tumor invasion and metastasis
    Tang, Zhigang
    Geng, Guangyong
    Huang, Qiang
    Xu, Geliang
    Hu, Hejie
    Chen, Jiong
    Li, Jiansheng
    MEDICAL ONCOLOGY, 2010, 27 (03) : 867 - 875
  • [46] The ERK/MAPK pathway regulates the activity of the human tissue factor pathway inhibitor-2 promoter
    Kast, C
    Wang, ML
    Whiteway, M
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (09) : 6787 - 6794
  • [47] Aberrant FHIT transcripts in squamous cell carcinoma of the uterine cervix
    Yoshino, K
    Enomoto, T
    Nakamura, T
    Nakashima, R
    Wada, H
    Saitoh, J
    Noda, K
    Murata, Y
    INTERNATIONAL JOURNAL OF CANCER, 1998, 76 (02) : 176 - 181
  • [48] Paradoxical pro-invasive effect of the serine proteinase inhibitor tissue factor pathway inhibitor-2 on human hepatocellular carcinoma cells
    Neaud, V
    Hisaka, T
    Monvoisin, A
    Bedin, C
    Balabaud, C
    Foster, DC
    Desmoulière, A
    Kisiel, W
    Rosenbaum, J
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (45) : 35565 - 35569
  • [49] Expression and localization of tissue factor pathway inhibitor-2 in normal and atherosclerotic human vessels
    Crawley, JTB
    Goulding, DA
    Ferreira, V
    Severs, NJ
    Lupu, F
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (02) : 218 - 224
  • [50] A novel role of tissue factor pathway inhibitor-2 in apoptosis of malignant human gliomas
    Tasiou, A
    Konduri, SD
    Yanamandra, N
    Dinh, DH
    Olivero, WC
    Gujrati, M
    Obeyesekere, M
    Rao, JS
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2001, 19 (03) : 591 - 597